What is Relmada Therapeutics, Inc.'s percenatge of net sales?

Relmada Therapeutics, Inc. (RLMD) reported percenatge of net sales of 3% in Q1 2025.

What does percenatge of net sales mean?

A ratio expressing a specific expense or financial item as a percentage of total net sales. It is used to benchmark operational efficiency and cost structure relative to revenue generation.

Relmada Therapeutics, Inc. RLMD Percenatge Of Net Sales

Percenatge Of Net Sales at other companies

RBC BearingsRBC

13%-5.0pp

Lands' End, Inc.LE

23.1%+0.3pp

PopularBPOP

$835.81M+10.3%

Quest DiagnosticsDGX

$252M+14.5%

Roku, Inc.ROKU

$85.7M+412%

Enerpac Tool GroupEPAC

$125.31M+10.0%

Other financials

Income statement

See full

Operating income-$19.5M-6.8%

Net income-$19.1M-8.5%

EPS (diluted)-$0.22+62.1%

Balance sheet

See full

Cash & equivalents$9.8M+750%

Total debt$104.1M-40.4%

Total equity$218.7M+875%

Total assets$235.4M+750%

Cash flow

See full

Operating cash flow-$15.1M+16.6%

Valuation

See full

Market cap$677.17M+2,907%

Returns & leverage

See full

Return on equity-48.8%-20.0pp

Debt / equity0.9×0.0×

Current ratio18.3×+13.0×

Where this comes from

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept rlmd:PercenatgeOfNetSales.

The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relmada Therapeutics, Inc.'s percenatge of net sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Relmada Therapeutics, Inc.'s percenatge of net sales?: Relmada Therapeutics, Inc. (RLMD) reported percenatge of net sales of 3% in Q1 2025.
What does percenatge of net sales mean?: A ratio expressing a specific expense or financial item as a percentage of total net sales. It is used to benchmark operational efficiency and cost structure relative to revenue generation.